Zeon has recently invested in Knowledge Palette, a company which develops AI drug discovery technology using single-cell transcriptome analysis. Knowledge Palette applies the world’s most accurate single-cell transcriptome analysis technology (Quartz-Seq2) to acquire large-scale data on the state of disease-causing cells. By using this information and AI technology to elucidate the causes of disease outbreaks, the company aims to efficiently...
Please subscribe to read the full story.
[lwa template="modal" register="0"]Subscribe
